Skip to main content

Investigator-Initiated Studies

We’re committed to supporting investigator-initiated research that promotes the advancement of medical and scientific knowledge involving AbbVie’s products and therapeutic areas of interest.

Advancing science through investigator-led research

The research from Investigator-Initiated Studies may expand our understanding of our products and their potential applications. Plus, it may improve patient care and spark new ideas for further disease-related research. The AbbVie IIS Program provides an opportunity to academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support.

How to apply

If you’re an investigator, you can initiate the application process by submitting a brief summary of the proposed research for AbbVie or legacy Allergan associated products through the:  IIS Study Submission Portal

IIS applications are accepted on a rolling submission basis.

How to Access Legacy Allergan Existing Studies

If you have an existing study in progress, please work with your designated AbbVie Representative (formerly your Allergan representative).

After you apply

Following the review of the initial submission, you may be asked to submit a full protocol and final study budget for further evaluation. We hold protocol review meetings monthly. Submission of a proposal does not imply or guarantee approval. The committee evaluates proposals according to their scientific merit, alignment with our areas of research interest and available funding. Financial and/or product support is contingent upon full execution of the research agreement by both parties.

Therapeutic areas of interest

Please refer to the following documents to learn more about our 2021 IIS strategic priorities:

Therapeutic areas of interest for legacy AbbVie associated products

Therapeutic areas of interest for legacy Allergan associated products

Support Resources

For assistance on submitting an IIS application or frequently asked questions, please refer to the following support resources below:

SPIRIT External Submission Guide

Quick Reference Guide (IIS Portal registration and study submission guidance)

Frequently Asked Questions

If you are unable to find answers to your questions in the resources above, please contact:  medicalresearchsupport@abbvie.com

For technical support, please contact the appropriate support team below:
Email: spirit@abbvie.com
Phone: +833-800-8338 (toll-free within the US) or follow the International toll-free instructions on the SPIRIT Submission Portal.